Company / Total Assets
Sunshine Biopharma Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$30.1M
FY2025
5-year range
$2.2M / $30.6M
FY2021-FY2025
Trend
-1.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 10 years, ranging from $64,404 in FY2016 to $31M in FY2024.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of +95.8%.
Improved from $27M to $30M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +0.9%
- 5-Year CAGR
- +95.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +95.8%, indicating consistent growth.
- In FY2025, total assets decreased 1.6% year-over-year.
- Peak total assets was recorded in FY2024.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.1M | -1.6% |
| FY2024 | $30.6M | +11.8% |
| FY2023 | $27.3M | -6.5% |
| FY2022 | $29.2M | +1227.5% |
| FY2021 | $2.2M | +110.7% |
| FY2020 | $1.0M | +965.3% |
| FY2019 | $98.1K | -91.4% |
| FY2018 | $1.1M | +345.3% |
| FY2017 | $257.5K | +299.8% |
| FY2016 | $64.4K | -90.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026